Evidence map›Paper›PMID 24164501›Full record

ArticleBiomacromolecules2013

mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I:C RNA.

Juan Reyes-Reveles, Reza Sedaghat-Herati, David R Gilley, Ashley M Schaeffer, Kartik C Ghosh, Thomas D Greene, Hannah E Gann, Wesley A Dowler, Stephen Kramer, John M Dean and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biomacromolecules, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Biocompatible FePONanoscale research letters · 2021
    Article
  4. Article
  5. Review
  6. ZnO Nanoparticles Protect RNA from Degradation Better than DNA.Nanomaterials (Basel, Switzerland) · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Juan Reyes-RevelesDepartments of ‡Biomedical Sciences, §Chemistry, and ∥Physics, Missouri State University , Springfield, Missouri 65897, United States.
Reza Sedaghat-Herati
David R Gilley
Ashley M Schaeffer
Kartik C Ghosh
Thomas D Greene
Hannah E Gann
Wesley A Dowler
Stephen Kramer
John M Dean
Robert K Delong
Missouri State University · US

Funding

Anti-Cancer RNA NanoconjugatesR15CA139390 · NCI · MISSOURI STATE UNIVERSITY · PI DELONG, ROBERT K., GARRAD, RICHARD C · 2009 to 2013
$640k
NCI NIH HHS 1R15CA139390-02NCI NIH HHS R15 CA139390
6 · The paper itself

Abstract

Dendrimer chemistries have virtually exploded in recent years with increasing interest in this class of polymers as gene delivery vehicles. An effective nucleic acid delivery vehicle must efficiently bind its cargo and form physically stable complexes. Most importantly, the nucleic acid must be protected in biological fluids and tissues, as RNA is extremely susceptible to nuclease degradation. Here, we characterized the association of nucleic acids with generation 4 PEGylated poly(amidoamine) dendrimer (mPEG-PAMAM-G4). We investigated the formation, size, and stability over time of the nanoplexes at various N/P ratios by gel shift and dynamic light scatter spectroscopy (DLS). Further characterization of the mPEG-PAMAM-G4/nucleic acid association was provided by atomic force microscopy (AFM) and by circular dichroism (CD). Importantly, mPEG-PAMAM-G4 complexation protected RNA from treatment with RNase A, degradation in serum, and various tissue homogenates. mPEG-PAMAM-G4 complexation also significantly enhanced the functional delivery of RNA in a novel engineered human melanoma cell line with splice-switching oligonucleotides (SSOs) targeting a recombinant luciferase transcript. mPEG-PAMAM-G4 triconjugates formed between gold nanoparticle (GNP) and particularly manganese oxide (MnO) nanorods, poly IC, an anticancer RNA, showed enhanced cancer-killing activity by an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assay.

Indexed as

Alternative SplicingAnimalsAntineoplastic AgentsCell Line, TumorCell SurvivalCircular DichroismDendrimersDrug CarriersFemaleHumansMelanomaMiceMicroscopy, Atomic ForceMolecular StructureNanostructuresNylonsAntineoplastic AgentsDendrimersDrug CarriersNylonsOligonucleotidesPAMAM-G4Polyethylene GlycolsPoly I-CRibonuclease, PancreaticRNA

Identifiers

PMID24164501
PMCPMC4295786
OpenAlexW2331002194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.